[Federal Register Volume 67, Number 24 (Tuesday, February 5, 2002)]
[Notices]
[Pages 5288-5289]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-2658]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Exploratory Developmental Grant (R21) Program, 
RFA OH-02-001

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:
    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Exploratory Developmental Grant (R21) 
Program, RFA OH-02-001.
    Times and Dates: 8 a.m.-8:30 a.m., February 19, 2002 (Open), 8:40 
a.m.-5 p.m., February 19, 2002 (Closed), 8 a.m.-5 p.m., February 20, 
2002 (Closed).
    Place: Loews L'Enfant Plaza Hotel, 480 L'Enfant SW., Washington DC 
20024.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c) (4) and (6), 
Title 5 U.S.C., and the

[[Page 5289]]

Determination of the Deputy Director for Program Management, CDC, 
pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to RFA 
OH-02-001.

FOR FURTHER INFORMATION CONTACT: Pervis Major, Ph.D., Scientific Review 
Administrator, National Institute for Occupational Safety and Health, 
CDC, 1095 Willowdale Road, M/S B228, telephone (304) 285-5979.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: January 30, 2002.
Alvin Hall,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 02-2658 Filed 2-4-02; 8:45 am]
BILLING CODE 4163-19-P